ARCOSA INC (ACA) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:ACA • US0396531008
116.605 USD
+0.23 (+0.19%)
Last: Feb 3, 2026, 02:25 PM
We assign a fundamental rating of 5 out of 10 to ACA. ACA was compared to 55 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of ACA get a neutral evaluation. Nothing too spectacular is happening here. ACA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year ACA was profitable.
- ACA had a positive operating cash flow in the past year.
- In the past 5 years ACA has always been profitable.
- Each year in the past 5 years ACA had a positive operating cash flow.
1.2 Ratios
- ACA's Return On Assets of 2.94% is in line compared to the rest of the industry. ACA outperforms 47.27% of its industry peers.
- With a Return On Equity value of 5.75%, ACA perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
- ACA has a Return On Invested Capital of 4.99%. This is comparable to the rest of the industry: ACA outperforms 47.27% of its industry peers.
- ACA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 15.97%.
- The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
- ACA has a better Profit Margin (5.25%) than 63.64% of its industry peers.
- ACA's Profit Margin has declined in the last couple of years.
- ACA has a better Operating Margin (10.27%) than 72.73% of its industry peers.
- In the last couple of years the Operating Margin of ACA has declined.
- The Gross Margin of ACA (21.61%) is better than 65.45% of its industry peers.
- In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
- The number of shares outstanding for ACA has been increased compared to 1 year ago.
- The number of shares outstanding for ACA has been increased compared to 5 years ago.
- The debt/assets ratio for ACA is higher compared to a year ago.
2.2 Solvency
- ACA has an Altman-Z score of 2.53. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.53, ACA is in line with its industry, outperforming 45.45% of the companies in the same industry.
- ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
- ACA's Debt to FCF ratio of 5.03 is fine compared to the rest of the industry. ACA outperforms 63.64% of its industry peers.
- ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
- ACA's Debt to Equity ratio of 0.61 is in line compared to the rest of the industry. ACA outperforms 58.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.53 |
ROIC/WACC0.5
WACC9.93%
2.3 Liquidity
- ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.02, ACA belongs to the top of the industry, outperforming 87.27% of the companies in the same industry.
- A Quick Ratio of 1.30 indicates that ACA should not have too much problems paying its short term obligations.
- ACA has a Quick ratio of 1.30. This is comparable to the rest of the industry: ACA outperforms 56.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
- ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.03%, which is quite good.
- The Earnings Per Share has been growing slightly by 5.16% on average over the past years.
- ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.96%.
- Measured over the past years, ACA shows a quite strong growth in Revenue. The Revenue has been growing by 8.15% on average per year.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
- ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.53% yearly.
- The Revenue is expected to grow by 7.33% on average over the next years.
EPS Next Y42.05%
EPS Next 2Y27.53%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue Next Year10.93%
Revenue Next 2Y8.42%
Revenue Next 3Y7.33%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 30.85, the valuation of ACA can be described as expensive.
- Based on the Price/Earnings ratio, ACA is valued a bit cheaper than 61.82% of the companies in the same industry.
- ACA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.41.
- A Price/Forward Earnings ratio of 23.82 indicates a rather expensive valuation of ACA.
- Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than the industry average as 74.55% of the companies are valued more expensively.
- ACA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.85 | ||
| Fwd PE | 23.82 |
4.2 Price Multiples
- 83.64% of the companies in the same industry are more expensive than ACA, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, ACA is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.18 | ||
| EV/EBITDA | 13.67 |
4.3 Compensation for Growth
- ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ACA's earnings are expected to grow with 22.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)5.97
EPS Next 2Y27.53%
EPS Next 3Y22.53%
5. Dividend
5.1 Amount
- ACA has a yearly dividend return of 0.17%, which is pretty low.
- ACA's Dividend Yield is a higher than the industry average which is at 0.14.
- With a Dividend Yield of 0.17, ACA pays less dividend than the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.17% |
5.2 History
- The dividend of ACA decreases each year by -0.48%.
- ACA has been paying a dividend for over 5 years, so it has already some track record.
- ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
- 6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y27.53%
EPS Next 3Y22.53%
NYSE:ACA (2/3/2026, 2:25:56 PM)
116.605
+0.23 (+0.19%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners94.81%
Inst Owner Change-3.09%
Ins Owners1.8%
Ins Owner Change-1.18%
Market Cap5.72B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target126.28 (8.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.17% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date01-15 2026-01-15 (0.05)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.34%
PT rev (3m)6.72%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)4.48%
EPS NY rev (1m)0.59%
EPS NY rev (3m)6.07%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.85 | ||
| Fwd PE | 23.82 | ||
| P/S | 2.02 | ||
| P/FCF | 18.18 | ||
| P/OCF | 12.19 | ||
| P/B | 2.21 | ||
| P/tB | 6.23 | ||
| EV/EBITDA | 13.67 |
EPS(TTM)3.78
EY3.24%
EPS(NY)4.9
Fwd EY4.2%
FCF(TTM)6.41
FCFY5.5%
OCF(TTM)9.57
OCFY8.21%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.73
PEG (5Y)5.97
Graham Number66.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.53 |
F-Score5
WACC9.93%
ROIC/WACC0.5
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y42.05%
EPS Next 2Y27.53%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.93%
Revenue Next 2Y8.42%
Revenue Next 3Y7.33%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
Can you provide the valuation status for ARCOSA INC?
ChartMill assigns a valuation rating of 6 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
How profitable is ARCOSA INC (ACA) stock?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What is the valuation of ARCOSA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 30.85 and the Price/Book (PB) ratio is 2.21.
How financially healthy is ARCOSA INC?
The financial health rating of ARCOSA INC (ACA) is 5 / 10.